CD8A and neoplasm: However, the authors pointed to a previous study suggesting that IL-6 promotes the induction of Th17 cells and therefore, the blockade of IL-6 may restore the balance of the Th17-Treg axis without affecting Th1-CD8+ T cells, that are required for effective tumor anti-tumor immunity (Figure 2) (175).